Stagezero Life Sciences Price to Book Ratio 2012-2024 | SZLSF
Historical price to book ratio values for Stagezero Life Sciences (SZLSF) over the last 10 years. The current price to book ratio for Stagezero Life Sciences as of June 05, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Stagezero Life Sciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-04 | 0.00 | 0.00 | |
| 2024-09-30 | 0.04 | $-0.09 | -0.44 |
| 2024-06-30 | 0.00 | $-0.09 | -0.02 |
| 2024-03-31 | 0.04 | $-0.08 | -0.42 |
| 2023-12-31 | 0.03 | 0.00 | |
| 2023-09-30 | 0.04 | $-0.07 | -0.55 |
| 2023-06-30 | 0.05 | $-0.07 | -0.67 |
| 2023-03-31 | 0.07 | $-0.08 | -0.78 |
| 2022-12-31 | 0.04 | $-0.07 | -0.62 |
| 2022-09-30 | 0.06 | $0.01 | 4.08 |
| 2022-06-30 | 0.06 | $0.01 | 4.44 |
| 2022-03-31 | 0.14 | $0.03 | 4.98 |
| 2021-12-31 | 0.23 | $0.03 | 7.58 |
| 2021-09-30 | 0.30 | $0.05 | 6.63 |
| 2021-06-30 | 0.38 | $0.01 | 49.35 |
| 2021-03-31 | 1.25 | $-0.07 | -18.09 |
| 2020-12-31 | 0.58 | $-0.02 | -28.81 |
| 2020-09-30 | 0.62 | $-0.17 | -3.77 |
| 2020-06-30 | 0.36 | $-0.08 | -4.52 |
| 2020-03-31 | 0.44 | $-0.17 | -2.63 |
| 2019-12-31 | 0.03 | $-0.13 | -0.22 |
| 2019-09-30 | 0.06 | $-0.16 | -0.39 |
| 2019-06-30 | 0.14 | $-0.37 | -0.38 |
| 2019-03-31 | 0.14 | $-0.44 | -0.31 |
| 2018-12-31 | 0.04 | $-0.29 | -0.13 |
| 2018-09-30 | 0.05 | $-0.29 | -0.17 |
| 2018-06-30 | 0.05 | $-0.26 | -0.20 |
| 2018-03-31 | 0.09 | $-0.19 | -0.45 |
| 2017-12-31 | 0.16 | $-0.20 | -0.77 |
| 2017-09-30 | 0.08 | $-0.29 | -0.28 |
| 2017-06-30 | 0.15 | $-0.36 | -0.43 |
| 2017-03-31 | 0.28 | $-0.47 | -0.59 |
| 2016-12-31 | 0.23 | $-0.46 | -0.50 |
| 2016-09-30 | 0.25 | $-0.69 | -0.37 |
| 2016-06-30 | 0.15 | $-0.63 | -0.23 |
| 2016-03-31 | 0.12 | $-0.54 | -0.23 |
| 2015-12-31 | 0.02 | $-0.25 | -0.06 |
| 2015-09-30 | 0.22 | $0.00 | -45.51 |
| 2015-06-30 | 0.29 | 0.00 | |
| 2015-03-31 | 0.59 | 0.00 | |
| 2014-12-31 | 1.56 | $0.34 | 4.61 |
| 2014-09-30 | 1.17 | 0.00 | |
| 2014-06-30 | 1.11 | 0.00 | |
| 2014-03-31 | 1.29 | 0.00 | |
| 2013-12-31 | 0.78 | $0.32 | 2.45 |
| 2013-09-30 | 0.39 | 0.00 | |
| 2013-06-30 | 0.89 | 0.00 | |
| 2013-03-31 | 0.83 | 0.00 | |
| 2012-12-31 | 0.65 | 0.00 | |
| 2012-09-30 | 0.76 | 0.00 | |
| 2012-06-30 | 0.85 | 0.00 | |
| 2012-03-31 | 0.92 | 0.00 | |
| 2011-12-31 | 0.98 | 0.00 | |
| 2011-09-30 | 1.18 | 0.00 | |
| 2011-06-30 | 1.32 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.004B |
| StageZero Life Sciences Ltd is dedicated to the early detection of cancer and multiple disease states through whole blood. The company's test consists of Aristotle(R), a multi-cancer panel for simultaneously screening for cancers from a single sample of blood. StageZero Life Sciences Ltd, formerly known as GeneNews Ltd., is based in TORONTO, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.380B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.233B | 23.84 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| LeMaitre Vascular (LMAT) | United States | $1.865B | 41.69 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 55.70 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |